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1. Introduction
The methods for coronary artery bypass grafting (CABG) have evolved rapidly in recent years.
Procedures such as the CABG without cardiopulmonary bypass (CPB), non-handling of the
ascending aorta (AA) and the search for better grafts are strategies that aim at reducing the
morbidity and mortality in the immediate postoperative period, the reduction of hospital stay
and the increase in expectation and quality of life of patients on long-term [1].
It is known that changes, especially at the cellular level, resulting from the blood flow by non-
endothelial surfaces in cardiopulmonary bypass (CPB), trigger the systemic inflammatory
response syndrome [2, 3]. The use of CPB, and inflammatory disorders, can cause coagulation
disorders with procoagulant effects and may cause early obstruction of the grafts [4], cerebral
embolic events with irreversible neurological damage [5-8], and susceptibility to infectious
processes due to immune depression in postoperative period [9].
The handling of AA is intrinsically related to the occurrence of cerebrovascular accident
(stroke), especially in elderly patients, either at the time of cannulation, clamping and un‐
clamping of the aorta to the installation and maintenance of the CPB circuit, to carry out the
proximal anastomosis of vascular grafts [10-12]. Some studies show that the handling of AA
is not the most important factor in reducing neurological complications [13, 14].
Another important factor for the improvement of CABG in the long term is the selection of the
grafts and the configuration thereof. It should be taken into account the specific anatomical
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and clinical conditions of each patient and the surgical team's experience in obtaining,
preparation and anastomosis of the grafts.
The use of composite graft setting in "Y", the left internal thoracic artery (LITA) with arterial
segments or segments of great saphenous vein (GSV) to revascularize both the left coronary
system (LCS) as the right is a technique widely described in literature, especially in patients
at high risk of stroke [15]. This procedure can be performed without CPB and without
manipulation of the AA, being the LITA the main source of blood supply to more than one
coronary artery. The LITA, in turn can also be used sequentially to the grafting of two or three
arteries of the left anterior descending artery (AD), being able to provide adequate blood
supply for the entire LCS, both at rest and stress [16].
Although the use of the GSV as aortocoronary graft is related to higher incidence of obstruc‐
tions than arterial grafts, especially the LITA, in short, medium and long-term disease called
aorto-coronary vein graft [17], it seems likely that the use valveless GSV segments in combi‐
nation with the LITA may modify these results [18, 19]. In our department we use routinely a
composite graft of LIMA and valveless GSV, in "Y" for the revascularization of arteries of the
LCS.
2. Surgical technique for CABG without CPB and without AA
manipulation using composite graft
After electrocardiographic monitoring of central venous pressure and mean arterial pressure,
the patient is anesthetized. Proceeding to the opening of the chest (sternotomy or left thora‐
cotomy), exposing finally the heart, the pericardium by setting the drapes. The LITA is
completely dissected from its origin until the seventh intercostal space, making up ligation of
all branches possible with a metal clip. Obtaining the saphenous vein graft is done preferen‐
tially by endoscopic dissection [20]. The procedure is anticoagulation by intravenous admin‐
istration of sodium heparin at doses of 1.0 mg / kg body weight, with accurate control of the
activated clotting time, which must be greater than 200 seconds [21]. We emphasize that both
the perfusionist as all the equipment for immediate installation of the CPB circuit is available
to the surgical team.
Being the grafts properly prepared, the coronary arteries to be grafted are dissected. The
interruption of blood flow to regions of the coronary arteries, where anastomosis shall be made
is performed by passing a 5-0 polypropylene line, in eight, with tourniquets proximal and
distal to the anastomosis site. Among the coronary and tourniquets, in order to protect the
coronary arterial bed, it is interposed a small segment (1.0 cm) of silicone tubes (Figure 1). The
intracoronary perfusates are only used in special situations.
The coronary artery is incised longitudinally, and anastomosis performed with the aid of a
tissue stabilizer (Figure 1), using a single polypropylene line 7-0 or 8-0 in cases of venous grafts
and 8-0 in the case of arterial grafts. Invariably, the LITA is anastomosed to the AD, and one
segment GSV, originating from the side of the LITA, revascularizes a second branch of the LCS
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(Figures 2 and 3). For revascularization of the posterior arteries, we used the Lima Point, which
facilitates the rotation of the mediastinum to the right [22].
Figure 2. Schematic of a composite graft of LITA with GSV revascularizing the AD and a marginal circumflex artery,
respectively
Figure 1. Protection of the coronary arterial bed with a small silicone tube segment number 10 on the occasion of the
coronary tourniquet. Device for stabilizing tissue in the anastomosis.
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Figure 3. Angiographic study of a composite graft of LITA revascularizing AD and one segment GSV originated from a
LITA revascularizing the circumflex marginal artery. Left anterior oblique cranial flow.
Figure 4. Schematic of a composite graft of LITA revascularizing AD and a GSV segment derived from the LITA revas‐
cularizing the 1st Diagonal and a second segment originating from GSV revascularizing a diagonal of the circumflex
marginal artery.
When other branches need to be revascularized, a second vein segment stems from the anterior
side of the vein segment (Figures 4 and 5). The venous segment can also be anastomosed
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sequentially. The evaluation of the flow of the grafts after preparing the same, using flowmetry
instruments is of paramount importance, being routinely performed in various facilities.
Figure 5. Angiography of a composite graft of LITA revascularizing AD and a GSV segment derived from the LITA re‐
vascularizing the 1st Diagonal and a second segment originating from the GSV revascularizing a diagonal of the cir‐
cumflex marginal artery. Examination 11 years after surgery.
3. Final considerations
In our department, since the mid-1990s, is routinely performed Off Pump Coronary artery
Bypass (OPCAB) surgery in 92% of patients with stable coronary artery disease. This associated
with the frequent use of LITA grafts composed of GSV and arteries for revascularization of the
LCS, with excellent results in terms of morbidity and Doppler or angiographic evaluation of
grafts in the short, medium and long term [23-25].
In the preoperative approach of patients we considered critically important the nutritional and
medicinal aspects. The reduction of sodium intake and calorie foods, weight loss, regarding
the increase of food of real nutrition and immunomodulator value are important. The admin‐
istration of statins, acetylsalicylic acid (ASA), beta-blockers is maintained until the day before
surgery, because they are related to the reduction of inflammatory response, lower incidence
of early thrombosis of grafts and prevention of atrial fibrillation in the post- surgery. Glycemic
control is done strictly to prevent infectious complications [26].
Regarding the preoperative examinations all patients underwent echocardiography, Doppler
study by the carotid and vertebral arteries and the venous system of lower limbs and abdomi‐
nal ultrasound evaluation, for abdominal aortic aneurysm screening.
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Regarding the operative aspects, we think the two biggest factors that increase morbidity and
mortality in CABG surgery is the use of CPB and the handling of AA. The CPB, as has been
explained, is related to inflammatory changes that may result in exacerbated systemic
inflammatory response syndrome affecting multiple organic. Studies clearly demonstrate the
association of CPB with brain [27], lung [28], kidney [29] and gastrointestinal [30] damage.
The CPB is still associated with higher levels of bleeding during and after surgery and therefore
with greater administration of blood products [31]. The use of these agents in turn, its associ‐
ated, in addition to the known complications of immunologic and infectious nature, to the
lower long-term survival [32]. Another important fact is that in OPCAB the dose of heparin
required for anticoagulation is small enough to achieve an activated clotting time greater than
200 seconds, thus the dose of protamine administered at the end of the procedure will be lower,
because this drug is related to a series of negative effects on the hemodynamic and inflamma‐
tory aspect [33].
The handling of AA, as well discussed, is intrinsically linked to embolic events when there is
atheromatous disease of the ascending aorta. However, beyond this fact, the partial or total
clamping of the aorta can cause aortic dissection [34].
In an era when one seeks a broader use of arterial grafts one might ask why the routine use of
GSV associated with LITA. First one must take into account the morbidity associated with
obtaining the grafts. Mediastinitis is a terrible complication associated with increased mortal‐
ity, with devastating consequences to the physical and psychological integrity of the patient
as well as repercussions in terms of financial cost on the public or private health system [35].
The use of two LITAs doubles the risk of internal thoracic mediastinitis compared to the use
of a single LITA [36] and can increase up to fourteen times the risk of this complication
associated with diabetes mellitus [37].
Regarding the use of the radial artery it is described that its dissection causes neurological
complications in about 30 percent of patients [38]. The radial artery is an artery muscle spasm
and susceptible to atrophy, especially when used to revascularize the coronary arteries without
severe stenosis [39, 40]. It is noteworthy that the angiographic results of radial artery grafts are
not superior to that of GSV grafts [41]. Obtaining gastroepiploic artery, in turn, brings the
disadvantage of opening of the peritoneal cavity, and similarly to the radial artery, it is prone
to spasm and thus it is only used for the revascularization of severe stenosed arteries [42].
Obtaining the GSV causes minimal morbidity, especially when done in an endoscopic manner.
It is a long graft, easy to handle and has no tendency to spasm. We consider of utmost
importance the venous Doppler study of lower limb in order to ascertain the GSV along its
entire length, the presence of valves and varicosities, and mark its location to better perform
the incisions for the dissection, with less tissue trauma and preservation of cosmetic and finally
the possibility of the preoperative preparation of another option, in those patients in which
GSV is not considered appropriate [43].
The obstruction of the GSV grafts occurs mainly by the action of three factors, which are
thrombosis, intimal hyperplasia and atherosclerosis [4, 44]. We think that the saphenous vein,
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the way we use it, can have a better behavior than those currently described, for the following
reasons:
1. The CABG procedure performed without CPB and, especially in the presence of AAS, has
a lower prothrombotic nature, which should be associated with lower rates of occlusion
of graft thrombosis [45].
2. The SV segments that we use are small and without valves, reducing the resistance to
blood flow and eliminating sites (valves) that favor the development of stenosis [4, 18, 46];
3. Lower blood pressure and circulatory stress imposed on segments of the saphenous vein
from the LITA, compared to those originating from the aorta, might cause less damage to
the intimate, less development of intimal hyperplasia and atherosclerosis [47, 48];
4. As the endothelium of the LITA is a major producer of nitric oxide, we believe that the SV
graft, originating from this artery, may receive part of this hormone, thereby decreasing
the incidence of atherosclerotic disease [44, 49];
5. hemodynamically the presence of the valve in the GSV segment can primarily cause
entrapment of blood between the coronary anastomosis and the valve due to the phe‐
nomenon of flow, natural in the blood circulatory system, with increasing pressure during
diastole with consequent stagnation of flow in venous segment; secondarily this flow
stagnation limits the infusion, in order to generate a vicious cycle, leading to obstruction
of the graft. This mechanism becomes responsible for 20% of cases of graft failure
following a year [18, 46].
In order to reduce the heart rate and decrease the energy consumption of the cardiomyocyte
during anastomoses, especially of the LITA to the AD, we administered esmolol, beta-blocker
of quick action, which has duration of action of about nine minutes. We believe that the use of
this drug to integrates the concept of myocardial protection in CABG surgery without CPB [50].
The increasing popularity of off-pump CABG surgery has brought concern, especially in
groups that start in the use of this technique, with the quality of anastomoses. Methods for
verification of graft patency in the intraoperative period are not commonly performed, and
most cardiovascular surgeons rely on electrocardiographic criteria, and hemodynamic enzyme
to make a diagnosis of early occlusion of grafts. The use of Transit-time flowmetry has been
adopted in many centers for CABG surgery with or without CPB [51].
In cases of elective surgery, epidural anesthesia with opioids and local anesthetic is routinely
performed. This procedure has a number of benefits beyond the appropriate component of
postoperative analgesia, such as increasing the diameter of epicardial arteries, improves flow
through collateral circulation, reduction of myocardial oxygen demand, decreased arrhyth‐
mias, lower rates of sternum infection and modulation of inflammatory activity [52, 53].
For the future we aim to allow our patients the benefits of revascularization by left minithor‐
acotomy with the aid of thoracoscopy [54] for cases of revascularization of arteries of the LCS
with or without percutaneous treatment of lesions of the right coronary artery or other vessels
[55]. We are still attentive to the evolution of epicardial ablation treatment for atrial fibrillation
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[56], as well as the development of efficient devices to exclude the left atrial appendage, focus
formation and embolization of 60-91%% of thrombi causing embolic ischemic stroke in validity
of this tachyarrhythmia [57].
Finally, we believe that surgical revascularization of the LCS can be systematically performed
without CPB and without manipulation of the AA, in order to reduce the systemic inflamma‐
tory response, blood transfusion, and mortality, particularly related to neurological compli‐
cations. Furthermore, the use of a valveless GSV grafts associated with LITA for coronary
artery bypass grafting of the LCS simplifies the technique of anastomosis "Y", making it more
physiological and, it may also be associated with a higher rate of graft patency in the long term.
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